Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
25,887,185
-
Shares change
-
+17,036,421
-
Total reported value, excl. options
-
$313,492,000
-
Value change
-
+$206,309,035
-
Number of buys
-
47
-
Number of sells
-
-1
-
Price
-
$12.11
Significant Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2015
50 filings reported holding LBIO - LION BIOTECHNOLOGIES INC - COM as of Q1 2015.
LION BIOTECHNOLOGIES INC - COM (LBIO) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,887,185 shares
.
Largest 10 shareholders include FMR LLC (5,747,328 shares), Ayer Capital Management, LP (5,604,015 shares), PERCEPTIVE ADVISORS LLC (2,714,549 shares), venBio Select Advisor LLC (2,149,907 shares), BAKER BROS. ADVISORS LP (1,325,000 shares), QVT Financial LP (1,325,000 shares), FRANKLIN RESOURCES INC (1,320,000 shares), Broadfin Capital, LLC (1,062,419 shares), ORBIMED ADVISORS LLC (1,000,000 shares), and Longwood Capital Partners LLC (669,196 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.